These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 27880937

  • 1. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, Westphal M, Hertenstein A, Roth P, Galldiks N, Hartmann C, Pietsch T, Felsberg J, Reifenberger G, Sabel MC, Winkler F, von Deimling A, Meisner C, Vajkoczy P, Platten M, Weller M, Plass C, Wick W.
    Oncotarget; 2016 Dec 13; 7(50):82028-82045. PubMed ID: 27880937
    [Abstract] [Full Text] [Related]

  • 2. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X.
    Exp Mol Med; 2015 Sep 04; 47(9):e182. PubMed ID: 26337869
    [Abstract] [Full Text] [Related]

  • 3. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M.
    J Clin Oncol; 2009 Dec 10; 27(35):5874-80. PubMed ID: 19901110
    [Abstract] [Full Text] [Related]

  • 4. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.
    Int J Clin Exp Pathol; 2015 Dec 10; 8(6):6576-88. PubMed ID: 26261539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
    Wang J, Sai K, Chen FR, Chen ZP.
    Cancer Chemother Pharmacol; 2013 Jul 10; 72(1):147-58. PubMed ID: 23645289
    [Abstract] [Full Text] [Related]

  • 8. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W, Ren X, Cai J, Zhang C, Li M, Wang K, Liu Y, Han S, Wu A.
    Oncotarget; 2015 Oct 06; 6(30):29285-95. PubMed ID: 26320189
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR, Switzeny OJ, Renovanz M, Sommer C, Kaina B, Christmann M, Tomicic MT.
    Oncotarget; 2017 Feb 28; 8(9):15071-15084. PubMed ID: 28122345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY, Yang P, Liu YW, Zhang CB, Wang KY, Wang YY, Yao K, Zhang W, Qiu XG, Li WB, Peng XX, Wang YZ, Jiang T.
    Sci Rep; 2016 Feb 16; 6():21141. PubMed ID: 26879272
    [Abstract] [Full Text] [Related]

  • 12. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A, Romeo SG, Cama A, La Torre D, Barresi V, Pezzino G, Tomasello C, Cardali S, Angileri FF, Polito F, Ferlazzo G, Di Giorgio R, Germanò A, Aguennouz M.
    Tumour Biol; 2016 Oct 16; 37(10):14035-14048. PubMed ID: 27495233
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methylation of the miR-126 gene associated with glioma progression.
    Cui H, Mu Y, Yu L, Xi YG, Matthiesen R, Su X, Sun W.
    Fam Cancer; 2016 Apr 16; 15(2):317-24. PubMed ID: 26463235
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG, Marand SV, Geraci S, Pycroft L, Berger FR, Pelletier LA.
    Oncotarget; 2015 Oct 06; 6(30):29456-68. PubMed ID: 26336131
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y.
    Int J Clin Exp Pathol; 2015 Oct 06; 8(1):727-34. PubMed ID: 25755767
    [Abstract] [Full Text] [Related]

  • 17. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H, Yu L, Liu J, Bian X, Shi C, Sun C, Zhou X, Wen Y, Hua D, Zhao S, Ren L, An T, Luo W, Wang Q, Yu S.
    Oncotarget; 2017 Mar 21; 8(12):19723-19737. PubMed ID: 28160566
    [Abstract] [Full Text] [Related]

  • 18. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S, Lottmann N, Stelzl A, Liesenberg F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, Reifenberger G, Riemenschneider MJ.
    Neuro Oncol; 2014 Jan 21; 16(2):179-90. PubMed ID: 24305703
    [Abstract] [Full Text] [Related]

  • 19. Methylation-mediated miR-155-FAM133A axis contributes to the attenuated invasion and migration of IDH mutant gliomas.
    Huang GH, Du L, Li N, Zhang Y, Xiang Y, Tang JH, Xia S, Zhang EE, Lv SQ.
    Cancer Lett; 2018 Sep 28; 432():93-102. PubMed ID: 29885519
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T, Liu P, Chen L, Chen Z, Luo Y, Chen X, Feng Y, Luo X.
    Clin Transl Oncol; 2015 Jul 28; 17(7):504-10. PubMed ID: 25575767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.